QuoteWhen will health officials finally connect the dots?
They indeed have these dots connected - maybe better than You.
Why do you think that Big Pharma Wants to Put an End to Vitamins and Supplements?
The Totally Civil Covid Thread. (Closing 31/05)
- Mark U
- Closed
-
-
A perfect example of British health officials putting lipstick on a pig. How much money did they pay Merck for this crap.
Pill for Covid does not reduce risk of hospitalisation or death, UK study finds
An oral antiviral pill for Covid speeds up recovery among vaccinated yet vulnerable patients, but does not reduce their likelihood of needing hospital care or dying, research has suggested.
The UK became the first country in the world in November 2021 to approve molnupiravir for Covid, with the pill – which can be taken twice a day at home – given to patients through the Panoramic (Platform Adaptive trial of NOvel antiviRals for eArly treatMent of Covid-19 In the Community) trial.
-
They indeed have these dots connected - maybe better than You.
Why do you think that Big Pharma Wants to Put an End to Vitamins and Supplements?
I'm sure you are correct but I'm more concerned with the NIH and the CDC. They provide medical information to the nation, not big pharma. It's their responsibility to provide medical information to protect the nation. They have failed on every level. Early treatment was never on the table.
-
Post-COVID-19 syndrome risk factors and further use of health services in East England
Post-COVID-19 syndrome risk factors and further use of health services in East EnglandPost-COVID syndrome, defined as symptoms persisting for more than twelve weeks after the diagnosis of COVID-19, has been recognised as a new clinical entity in…journals.plos.orgAbstract
Post-COVID syndrome, defined as symptoms persisting for more than twelve weeks after the diagnosis of COVID-19, has been recognised as a new clinical entity in the context of SARS-CoV-2 infection. This study was conducted to characterise the burden and predictors for post-COVID-19 syndrome in the local population. It was a community-based web-survey study conducted in Norfolk, East England, UK. We sent the survey to patients with confirmed COVID-19 infection by real-time polymerase chain reaction by December 6th, 2020. Questions related to the pre-COVID and post-COVID level of symptoms and further healthcare use. Baseline characteristics were collected from the primary care records. Logistic regression analysis was conducted to establish predictors for post-COVID-19 syndrome and further healthcare utilisation. Of 6,318 patients, survey responses were obtained from 1,487 participants (23.5%). Post-COVID-19 syndrome symptoms were experienced by 774 (52.1%) respondents. Male sex compared to female sex was a factor protective of post-COVID symptoms; relative risk (RR) 0.748, 95% confidence interval (CI), 0.605–0.924. Body mass index was associated with a greater risk of developing post-COVID-19 symptoms (RR 1.031, 95% CI, 1.016–1.047, for 1 kg/m2). A total of 378 (25.4%) people used further health services after their index COVID-19 infection, of whom 277 (73.2%) had post-COVID symptoms. Male sex was negatively associated with the use of further health services (RR 0.618, 95% CI, 0.464–0.818) whereas BMI was positively associated (RR 1.027, 95% CI, 1.009–1.046). Overall, post-COVID-19 symptoms increased the probability of using health services with RR 3.280, 95% CI, 2.540–4.262. This survey of a large number of people previously diagnosed with COVID-19 across East England shows a high prevalence of self-reported post-COVID-19 syndrome. Female sex and BMI were associated with an increased risk of post-COVID-19 syndrome and further utilisation of healthcare.
Obesity and Vitamin D Insufficiency among Adolescent Girls and Young Adult Women from Korea
Obesity and Vitamin D Insufficiency among Adolescent Girls and Young Adult Women from KoreaAlthough there is evidence of the biological mechanisms by which obesity may induce vitamin D insufficiency or deficiency, limited epidemiological studies have…www.mdpi.comThe association between 25(OH)D levels, frailty status and obesity indices in older adults
The association between 25(OH)D levels, frailty status and obesity indices in older adultsBackground Vitamin D deficiency is common in older adults and has been linked with frailty and obesity, but it remains to be studied whether frail obese older…journals.plos.org -
The UK became the first country in the world in November 2021 to approve molnupiravir for Covid, with the pill – which can be taken twice a day at home – given to patients through the Panoramic (Platform Adaptive trial of NOvel antiviRals for eArly treatMent of Covid-19 In the Community) trial.
Here the paper source:: https://www.thelancet.com/acti…S0140-6736%2822%2902593-4
Merck crap is a bit more deadly....than standard care..
I'm sure you are correct but I'm more concerned with the NIH and the CDC. They provide medical information to the nation, not big pharma. It's their responsibility to provide medical information to protect the nation.
Once more:: CDC is big pharma. They recruit members exclusively from big pharma sponsored projects... Same here in Switzerland/Germany etc...
-
Here the paper source:: https://www.thelancet.com/acti…S0140-6736%2822%2902593-4
Merck crap is a bit more deadly....than standard care..
Once more:: CDC is big pharma. They recruit members exclusively from big pharma sponsored projects... Same here in Switzerland/Germany etc...
collusion between big pharma and the NIH will be in nvestigated by a Florida grand jury and soon by a republican congress.i hope these investigations bring results but I'm not holding my breath.
-
Florida high court OKs grand jury probe of COVID-19 vaccines
Florida high court OKs grand jury probe of COVID-19 vaccinesTALLAHASSEE (AP) — The Florida Supreme Court will convene a grand jury at Republican Gov. Ron DeSantis’ request to investigate any wrongdoing with respect to…apnews.comTALLAHASSEE (AP) — The Florida Supreme Court will convene a grand jury at Republican Gov. Ron DeSantis’ request to investigate any wrongdoing with respect to the COVID-19 vaccines, the court announced Thursday.
The Republican governor, who is often mentioned as a possible presidential candidate in 2024, earlier this month called for the investigation. He suggested it would be in part aimed to jog loose more information from pharmaceutical companies about the vaccines and potential side effects.
-
Pfizer’s Regulatory Violation Fines Exceed $10 Billion but Operations Continue
Pfizer’s Regulatory Violation Fines Exceed $10 Billion but Operations ContinueCorporate crime tracking data shows that US-based pharmaceutical giant Pfizer and its subsidiaries have paid over $10bn in penalties for 91 regulatory…www.trialsitenews.comCorporate crime tracking data shows that US-based pharmaceutical giant Pfizer and its subsidiaries have paid over $10bn in penalties for 91 regulatory violations from the year 2000 until the present. The most common offenses include drug safety violations, false claims, and foreign corrupt practices, with payouts ranging from $5,000 to $2.3bn and a record high of $3.75bn by a subsidiary prior to acquisition.
Pfizer Inc. is a multinational pharmaceutical and biotechnology corporation with 52 locations around the world and headquarters in New York. As of the first nine months of 2022, the company has made over $76bn in revenues from both the parent organization and all its subsidiaries.
Despite being such a large corporation that many rely on for life-saving medications, Pfizer –and its subsidiaries – has been implicated in a whopping 91 regulatory violations since the year 2000 that have resulted in the payment of a monetary fine.
Violation Tracker (US) is a database currently containing 546,000 cases of corporate misconduct starting in 2000. The majority of these cases were resolved by federal regulatory agencies or the US Department of Justice. While the US version is the first of its kind, the database has also been adapted for the UK. Each entry in Violation Tracker includes a link to a primary source of the litigation news - such as a US Department of Justice release – as well as tags and categories for the type of misconduct.
According to Violation Tracker, a large proportion of Pfizer’s lawsuits were at the state and federal levels. In total, they have paid over $10bn in fines and settlements, but that does not seem to deter the company from continually breaking the law.
Overview of Violations and Settlements
In 2009, Pfizer paid a record-high fine of $2.3bn in US civil and criminal penalties. The US Justice Department refers to this as the “largest health care fraud settlement in its history.” The fraud consisted of misleading marketing for the drug Bextra (now off the market), which Pfizer and subsidiaries were marketing for off-label uses not authorized by the FDA. This litigation was hot off the heels of another Pfizer lawsuit, concerning illegal kickbacks to healthcare practitioners to prescribe the drugs Geodon, Zyvox, and Lyrica preferentially and for unauthorized uses.
That was not the last time Pfizer was sued for illegal kickbacks. In May 2018, the company faced a False Claims Act charge, which they settled for $23.8m. This litigation involved the drugs Sutent, Inlyta, and Tikosyn, which Pfizer was essentially coercing patients to use. By raising drug prices to the point where Medicare patients could not afford the drug, then referring them to a Pfizer-sponsored fund, Pfizer was able to ensure the loyalty of patients receiving those drugs. According to Acting Assistant Attorney General Chad A. Readler of the Justice Department’s Civil Division, this diminishes the agency and decision-making of patients and healthcare providers.
Apart from monetary fines, there is also mention of Pfizer entering into a Corporate Integrity Agreement (CIA) as part of their $23.8m settlement. Note that Pfizer entered into a CIA with the Office of Inspector General of the Department of Health and Human Services in 2009 as a result of their $2.3bn settlement with subsidiary Pharmacia & Upjohn Co. Inc. Continued criminal behavior suggests an ineffectiveness of the government-imposed CIAs.
Pfizer’s most recent settlement involved four states including Colorado, Vermont, Arizona, and Kansas. The states filed lawsuits against Pfizer for not following through with coupons promised to consumers for three Pfizer medications. As a result, Pfizer settled by paying $107,000 to failed customers and $30,000 to the Colorado Attorney General’s Office for litigation fees.
It is noteworthy that in 2002, American Home Products settled litigation for alleged harms due to their dietary drug fen-phen with a payout of $3.8bn. American Home Products later changed its name to Wyeth in March 2002 and was acquired by Pfizer in 2009. This litigation is not directly under Pfizer as it was not the parent company at the time, but the large settlement did not deter the acquisition.
How Pfizer Emerges Virtually Unscathed
This criminal record does not stop the company from operating, as they continue to produce pharmaceuticals and conduct research well into 2022. Despite billions of dollars paid in fines, Pfizer may avoid repercussions that permanently damage company operations and profit margins primarily through accommodating costs in the overhead costs (i.e., paying for costs through gross profits) or having one of their subsidiaries ‘take the fall’.
Fines as part of an overhead cost
According to Duke University School of Law professor Brandon Garrett, corporations often shell out settlement payments from profits. For the year 2021, Pfizer Inc. and its subsidiaries reported a total of $21bn in net income attributable to common shareholders, which is a measure of the maximum amount a company can choose to pay out to shareholders after all other operating costs and taxes, and can be representative of Pfizer’s profit in 2021. In 2020, they reported $9bn. Even the largest fine paid by Pfizer to date would not put a large dent in their gross profits.
Furthermore, Pfizer has experienced almost double in its revenue from 2020 to 2021 thanks to pandemic-related profits largely from Comirnaty and Paxlovid. According to Pfizer’s 2021 annual report, the total revenue from Comirnaty alone was $36bn, reflecting the over 3 billion doses manufactured and sold by the corporation.
Paxlovid is an antiviral that has been authorized for emergency use for treating early-stage COVID-19 and is proposed to reduce the risk factors associated with COVID-19 by 89%. However, like with the Comirnaty vaccine, experts question the effectiveness of this drug against new COVID-19 variants. Nevertheless, the US government paid $5.29bn for 10 million doses in 2021, planned to be in use until 2022. From 2022 until 2023, Pfizer will be providing an additional 3.7 million doses to the US and 3.4 million to the EU. These numbers will serve to further bolster Pfizer’s gross profit margins in the future.
Subsidiary scapegoats
Pfizer may continue to operate because, as stated by Garrett concerning megacorporations committing crimes, the company is “too big to jail”. This idea is supported by the charges surrounding Pfizer’s $2.3bn settlement. According to an article published in April of the following year after news broke in September 2009, Pfizer itself was not charged with healthcare fraud because that would exclude the corporation from Medicare and Medicaid. Such an exclusion would simultaneously decimate Pfizer’s profit and dismantle medical security for patients who will no longer have access to their essential Pfizer medications.
Consequently, Pfizer’s subsidiary—Pharmacia & Upjohn Co. Inc.—was charged with a felony violation with the intent to defraud or mislead and faced exclusion from Medicare and Medicaid. Pharmacia & Upjohn Co. Inc. is not directly owned by Pfizer, but rather the article labels it the “great-great-grandson of the parent company” Considering that, as of 2021, Pfizer (ticker symbol PFE) owns 285 subsidiaries recognized by the US Securities and Exchange Commission (SEC), which may have additional subsidiaries under them, it is easy to see how the company can sacrifice less profitable subsidiaries without risking the parent company.
Bottom Line
A company as large as Pfizer appears to have a few of ways to evade criminal charges, either by using large profits brought in by all their operations, or sacrificing smaller subsidiaries that will not impact the company’s net gain.
Pfizer’s own statements on these monetary fines place an emphasis on moving forward without explicit recognition of fault. For instance, Pfizer’s General Counsel at the time of their $2.3bn settlement, Amy Schulman, stated, “We regret certain actions taken in the past, but are proud of the action we’ve taken to strengthen our internal controls.” On the topic of their $23.8m settlement, Pfizer indicated in an announcement that “This resolution reflects the company’s desire to put this legal matter behind it and focus on the needs of patients.” The same announcement suggests that Pfizer self-reported in 2017 via a government-issued subpoena, and refers to the government ruling as “allegations”, with no acknowledgment of the False Claims Act Liability or for paying kickbacks.
This continual evasion also calls into question the effectiveness of existing penalties for corporations of this size. Garrett believes the largely inconsequential penalties may encourage companies to maximize profits in ways that willingly break the law, and this question emerges: Are the government and law-enforcing agencies doing enough to really discourage companies from breaking the law?
-
Respiratory mucosal vaccination of peptide-poloxamine-DNA nanoparticles provides complete protection against lethal SARS-CoV-2 challenge
Respiratory mucosal vaccination of peptide-poloxamine-DNA nanoparticles provides complete protection against lethal SARS-CoV-2 challengeThe ongoing SARS-CoV-2 pandemic represents a brutal reminder of the continual threat of mucosal infectious diseases. Mucosal immunity may provide robu…www.sciencedirect.comAbstract
The ongoing SARS-CoV-2 pandemic represents a brutal reminder of the continual threat of mucosal infectious diseases. Mucosal immunity may provide robust protection at the predominant sites of SARS-CoV-2 infection. However, it remains unclear whether respiratory mucosal administration of DNA vaccines could confer protective immune responses against SARS-CoV-2 challenge due to insurmountable barriers posed by the airway. Here, we applied self-assembled peptide-poloxamine nanoparticles with mucus-penetrating properties for pulmonary inoculation of a COVID-19 DNA vaccine (pSpike/PP-sNp). The pSpike/PP-sNp not only displays superior gene transfection and favorable biocompatibility in the mouse airway, but also promotes a tripartite immunity consisting of systemic, cellular, and mucosal immune responses that are characterized by mucosal IgA secretion, high levels of neutralizing antibodies, and resident memory phenotype T-cell responses in the lungs of mice. Most importantly, immunization with pSpike/PP-sNp completely eliminates SARS-CoV-2 infection in both upper and lower respiratory tracts and enables 100% survival rate of mice following lethal SARS-CoV-2 challenge. Our findings indicate PP-sNp is a promising platform in mediating DNA vaccines to elicit all-around mucosal immunity against SARS-CoV-2.
LL-37 fights SARS-CoV-2: The Vitamin D-Inducible Peptide LL-37 Inhibits Binding of SARS-CoV-2 Spike Protein to its Cellular Receptor Angiotensin Converting Enzyme 2 In Vitro
LL-37 fights SARS-CoV-2: The Vitamin D-Inducible Peptide LL-37 Inhibits Binding of SARS-CoV-2 Spike Protein to its Cellular Receptor Angiotensin Converting Enzyme 2 In VitroObjective Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is the pathogen accountable for the coronavirus disease 2019 (COVID-19) pandemic. Viral…www.biorxiv.orgAbstract
Objective Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is the pathogen accountable for the coronavirus disease 2019 (COVID-19) pandemic. Viral entry via binding of the receptor binding domain (RBD) located within the S1 subunit of the SARS-CoV-2 Spike (S) protein to its target receptor angiotensin converting enzyme (ACE) 2 is a key step in cell infection. The efficient transition of the virus is linked to a unique protein called open reading frame (ORF) 8. As SARS-CoV-2 infections can develop into life-threatening lower respiratory syndromes, effective therapy options are urgently needed. Several publications propose vitamin D treatment, although its mode of action against COVID-19 is not fully elucidated. It is speculated that vitamin D’s beneficial effects are mediated by up-regulating LL-37, a well-known antimicrobial peptide with antiviral effects.
Methods Recombinantly expressed SARS-CoV-2 S protein, the extended S1 subunit (S1e), the S2 subunit (S2), the receptor binding domain (RBD), and ORF8 were used for surface plasmon resonance (SPR) studies to investigate LL-37’s ability to bind to SARS-CoV-2 proteins and to localize its binding site within the S protein. Binding competition studies were conducted to confirm an inhibitory action of LL-37 on the attachment of SARS-CoV-2 S protein to its entry receptor ACE2.
Results We could show that LL-37 binds to SARS-CoV-2 S protein (LL-37/SStrep KD = 410 nM, LL-37/SHis KD = 410 nM) with the same affinity, as SARS-CoV-2 binds to hACE2 (hACE2/SStrep KD = 370 nM, hACE2/SHis KD = 370 nM). The binding is not restricted to the RBD of the S protein, but rather distributed along the entire length of the protein. Interaction between LL-37 and ORF8 was detected with a KD of 290 nM. Further, inhibition of the binding of SStrep (IC50 = 740 nM), S1e (IC50 = 170 nM), and RBD (IC50 = 130 nM) to hACE2 by LL-37 was demonstrated.
Conclusions We have revealed a biochemical link between vitamin D, LL-37, and COVID-19 severity. SPR analysis demonstrated that LL-37 binds to SARS-CoV-2 S protein and inhibits binding to its receptor hACE2, and most likely viral entry into the cell. This study supports the prophylactic use of vitamin D to induce LL-37 that protects from SARS-CoV-2 infection, and the therapeutic administration of vitamin D for the treatment of COVID-19 patients. Further, our results provide evidence that the direct use of LL-37 by inhalation and systemic application may reduce the severity of COVID-19.
-
Ups:: Masks don't work ?! : https://www.thedesertreview.co…ed-b3fe-379aa32369df.html
... Dr. Tracy Høeg and Ambarish Chandra examined data from 565 counties. They found counties without mask mandates had additional cases after two weeks of schools reopening, but after nine weeks, the difference was not statistically significant.
It's all about how to fake the data. Ask Pfizer's Israel mafia how they do it with vaxx and kill --> CoV-19 deaths..
-
French Study Finds Glycan-Binding Agent Ivermectin Blocks SARS-CoV-2 Spike-Protein Induced Hemagglutination
French Study Finds Glycan-Binding Agent Ivermectin Blocks SARS-CoV-2 Spike-Protein Induced HemagglutinationA prominent France-based research team at IHU-Mediterranee Infection in Marseille, led by prof. Bernard La Scola, included prominent collaborators from…www.trialsitenews.comA prominent France-based research team at IHU-Mediterranee Infection in Marseille, led by prof. Bernard La Scola, included prominent collaborators from Aix-Marseille University, Publique—Hôpitaux de Marseille (AP-HM), the Institut de Recherche pour le Développement or IRD--a French science and technology establishment under the joint supervision of the French Ministries of Higher Education and Research and Foreign Affairs, and American contributor to TrialSite, David Scheim. The team came together to publish an open access article recently titled “SARS-CoV-2 Spike Protein Induces Hemagglutination: Implications for COVID-19 Morbidities and Therapeutics and for Vaccine Adverse Events.”
Key to infectivity and morbidity associated with SARS-CoV-2, the virus behind COVID-19, the France-based team zeroed in on glycan biochemistry of coronaviruses such as SARS-CoV-2. They point out that associated morbidity and mortality associated with the attachments from spike protein to glycoconjugates on the surfaces of red blood cells (RBCs), other blood cells and endothelial cells.
The study group applied a classic hemagglutination (HA) along with human red blood cells (RBC) to test the spike protein across a range of variants from the original wildtype (Wuhan) to Alpha, Delta, and Omicron B.1.1.529 lineages of SARS-CoV-2. The goal is to offer further insight into such glycan attachments and possible clinical implications.
Getting Granular
Focusing on the four lineages mentioned above, the team sought to better understand the electrostatic potential specifically of the central region of the spike protein across all four lineages via molecular modeling simulations.
The Study: Does Ivermectin Inhibit Spike Protein-induced HA?
The French team sought to better understand the potential of macrocyclic lactone ivermectin (IVM) as an inhibitor of SARS-CoV-2 spike protein-induced HA—“indicated to bind strongly” to spike protein glycan sites.
The Findings
So, what did Prof. Bernard La Scola and colleagues find? The authors point out that “the spike protein from these four lineages of SARS-CoV-2 induced HA.” Interestingly, they report, “Omicron induced HA at a significantly lower threshold concentration of spike protein than the three major lineages and was more electropositive on its central spike region.”
The study authors point out that when the French team added ivermectin to the red blood cells in the lab before infusing the spike protein, ivermectin served to block HA. Moreover, when the researchers added ivermectin after infusion of the spike protein the economical well-known drug actually reversed HA.
What’s the implications of the study findings?
This group of experiments validated and enhanced previous research examining the role of glycan bindings of viral spike protein in COVID-19. Importantly, the authors, despite the controversy involving ivermectin—(the medical establishment has overwhelmingly rejected any claims of efficacy involving COVID-19 based on a handful of prominent studies while ignoring dozens of studies showing positive results)—suggest that “competitive glycan-binding agents such as ivermectin” may represent therapeutic options.
But the team also raises the specter of COVID-19 vaccine-induced spike protein related injury. Their findings “may help elucidate rare serious side effects (AEs) associated with COVID-19 mRNA vaccines, which use the spike protein as the generated antigen.”
SARS-CoV-2 Spike Protein Induces Hemagglutination: Implications for COVID-19 Morbidities and Therapeutics and for Vaccine Adverse EffectsExperimental findings for SARS-CoV-2 related to the glycan biochemistry of coronaviruses indicate that attachments from spike protein to glycoconjugates on the…www.mdpi.com -
Sudden cardiac arrest: ICMR to probe Covid link
Sudden cardiac arrest: ICMR to probe Covid link | India News - Times of IndiaIndia News: NEW DELHI: The Indian Council of Medical Research is conducting a study to find out the reason behind a sudden rise in cardiac arrests and the role…timesofindia.indiatimes.comNEW DELHI: The Indian Council of Medical Research is conducting a study to find out the reason behind a sudden rise in cardiac arrests and the role of Covid, if any.
It will involve a review of the recent cases of sudden cardiac arrests reported from the country and verbal autopsy - a method of gathering information about symptoms and circumstances for a deceased person to determine their cause of death.
-
The study authors point out that when the French team added ivermectin to the red blood cells in the lab before infusing the spike protein, ivermectin served to block HA. Moreover, when the researchers added ivermectin after infusion of the spike protein the economical well-known drug actually reversed HA.
Already 2 years ago a computational pharma team made calculations about the fitting strength of Ivermectin and others to the spike protein. Ivermectin always was in the top 3. This means its a perfect antibody. But as a such it gets consumed and can no longer block replication. This is the main reason behind the higher dose needed after day 1 of infection....
But once a capillary is blocked Ivermectin will no longer reach the target and may be other (smaller) blood thinners will help better.
-
The New "Great Masquerader"
Wide Range of Neurologic Syndromes after COVID-19 Vaccination
The New "Great Masquerader"Wide Range of Neurologic Syndromes after COVID-19 Vaccinationpetermcculloughmd.substack.comBy Peter A. McCullough, MD, MPH
Before the COVID-19 era, for ages in medicine it has been said: “Syphilis is often referred to as “the great masquerader,” as it may present with a wide array of clinical symptoms and may mimic a variety of other diseases making diagnosis challenging.” There is no doubt that COVID-19 vaccine injury syndromes will far eclipse syphilis, sarcoidosis, amyloidosis, or any other systemic disorder and will assume the throne of “the great masquerader”. In a recent issue of Current Neurology and Neuroscience Reports, Chatterjee and Chakravarty, report on the wide range of central nervous system and peripheral nervous system syndromes that occur after COVID-19 vaccination.[i]
-
Interesting effect of increased activity on mortality : https://jamanetwork.com/journa…24-4946-b15e-1b2824dfc696
Increasing MVPA by 10, 20, or 30 minutes per day was associated with a 6.9%, 13.0%, and 16.9% decrease in the number of deaths per year, respectively.
-
More screen (TV) time at age 1 correlates with increase of autism... https://jamanetwork.com/journa…90-4899-86f1-53fc7daa3ef0
CoV-19 school etc.. closure side effect..
-
Memory loss from the first jabs is starting to surface.
likely not going to be reported
-
Two Babies Die, Likely from Their Mothers' First Trimester Covid Vaccines
RESCUE with Michael CapuzzoJoin me, a New York Times-bestselling author, and editor Teresa Banik Capuzzo (my wife) for the world's finest reporting on the best COVID-19 doctors and…rescue.substack.comThis article is about two beautiful babies, Makenna and Edison, and the mothers who mourn them.
It is also about what likely doomed them, according to doctors and scientists who investigate vaccine harms, as the babies grew cell by cell within the womb, from healthy to harmed to the clinical, horrific category of demise.
-
Top Japanese Physician-Scientist Gives Dire Warning About COVID-19 mRNA Vaccines: ‘Scientifically Misconceived’
Top Japanese Physician-Scientist Gives Dire Warning About COVID-19 mRNA Vaccines: ‘Scientifically Misconceived’Dr. Masanori Fukushima, a professor emeritus at Kyoto University, presented a warning on November 25, 2022, at an event organized by Kazuhisa Ukawa, a…www.trialsitenews.comDr. Masanori Fukushima, a professor emeritus at Kyoto University, presented a warning on November 25, 2022, at an event organized by Kazuhisa Ukawa, a concerned private citizen. Apparently on the agenda were concerns involving discrimination against the unvaccinated in Japan as well as an ever-growing list of persons reporting injuries associated with the COVID-19 mRNA vaccines. In what frankly can be described as a bombshell acknowledgment given the pedigree of this physician-scientist in Japanese medical research circles, Fukushima declared that “the harm caused by vaccines is now a worldwide problem” and that “given the wide range of adverse events, billions of lives could ultimately be in danger.” Is this just reactionary hyperbole of a bitter critic or a prescient signal to be taken very seriously?
Involved with the Foundation for Biomedical Research and Innovation and the Translational Research Center for Medical Innovation, the infectious disease expert (Fukushima) has been an oncologist with over 25 years of experience in practice and research, including ongoing reform of Japan’s medical care system.
A big proponent of clinical research, Fukushima has actively contributed to building the clinical trial infrastructure, with a focus on translational research. In this recent video of the conference uploaded to Rumble Fukushima told the audience that “Vaccine damage now represents a global problem. Billions of lives at possible risk.” But could this be true? Does this include some hyperbolic alarmism?
Dr. Masanori Fukushima
What does the physician-scientist share during this conference?
He starts out by saying that “this vaccine was scientifically misconceived. So, in 2020 I immediately translated the Chinese guidelines as soon as they arrived from China to use steroids as appropriately as possible.” He emphasized he made such a proclamation but that such messaging fell on deaf ears.
Complimenting Japan’s excellent doctors, the prominent physician-scientist emphasized that once he released unfolding guidelines involving early care with the use of drugs such as steroids, the death rate [in Japan] dropped dramatically before the vaccine. Harboring some clear resentment, Fukushima declared, “So anyone inciting this vaccine without any academic acumen is to be condemned.”
Then comes the Fukushima bombshell: “The harm caused by vaccines is now a worldwide problem. Here is my article recently published. Shall we read it? Given the large number of people who have received vaccinations and given the wide range of adverse events, billions of lives could ultimately be in danger.”
What is Dr. Fukushima demanding?
The doctor went on the record at this Japanese event:
“We urge public health agencies to acknowledge or substantiate the issues raised in this document that are relevant to public health. Recognize them and act accordingly. Also, ensure that all individuals make their own decision on the matter.”
Conveying that the medical community has an obligation to investigate this matter in pursuit of their duty of helping patients, he calls for healthcare professionals to start making their own decisions.
TrialSite also includes a Twitter link to this event. The video is hosted on multiple channels but not on YouTube. See another video capture of the same event in Japan.
A growing chorus of concern about mRNA COVID-19 vaccine safety and the need to not only recognize vaccine injury but the need to care for the injured becomes a fundamentally important unfolding event. It’s not an either-or, vaxxed vs. unvaxxed, or a liberal vs. conservative false dilemma. The COVID-19 vaccines represented an emergency response to a dangerous pandemic, and these vaccines, during bursts of time, did bring down the risks of serious COVID-19—less the unknown risk factors associated with the COVID-19 vaccines. But it’s time for the mainstream to start recognizing the problem.
Recently TrialSite reported that a New England Skeptical Society affiliated physician, Dr. Frank Han, while attacking many of the participants involved with Senator Ron Johnson’s recent roundtable on COVID-19 vaccine safety, did acknowledge an urgent need to support the COVID-19 vaccine-injured. See the link.
NESS Writer Attacks Sen. Ron Johnson’s SARS-CoV-2 Vaccine Injury-Related RoundtableThe New England Skeptical Society (NESS), via their blog Science-based Medicine, took a particularly nasty swipe at Senator Ron Johnson’s recent…www.trialsitenews.com -
three weeks ago.. masks for confetti..
Dr. Masanori Fukushima
External Content youtu.beContent embedded from external sources will not be displayed without your consent.Through the activation of external content, you agree that personal data may be transferred to third party platforms. We have provided more information on this in our privacy policy.
